Consilium Wealth Advisory, LLC Abbott Laboratories Transaction History
Consilium Wealth Advisory, LLC
- $182 Million
- Q2 2024
A detailed history of Consilium Wealth Advisory, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Consilium Wealth Advisory, LLC holds 3,744 shares of ABT stock, worth $423,446. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,744
Previous 13,036
71.28%
Holding current value
$423,446
Previous $1.48 Million
73.73%
% of portfolio
0.21%
Previous 0.84%
Shares
11 transactions
Others Institutions Holding ABT
# of Institutions
3,131Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.41 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.12 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.47 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $198B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...